These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Update on regulatory framework and certification process]. Legrand D. Transfus Clin Biol; 2008 Nov; 15(5):193-6. PubMed ID: 18930686 [Abstract] [Full Text] [Related]
3. [Conditions for blood components return, after storage in a depot]. Hervé I, Girard A. Transfus Clin Biol; 2008 Nov; 15(5):201-4. PubMed ID: 18930688 [Abstract] [Full Text] [Related]
5. [Report on the activity of the blood bank accreditation program (1987-1995)]. Pinto V, Algora M, Blanco L, Carpio N, Cortés A, Muñiz E, Oyonarte S, Puig L, Rodríguez J, Vesga MA. Sangre (Barc); 1998 Jun; 43(3):196-201. PubMed ID: 9741225 [Abstract] [Full Text] [Related]
6. [Serious events: from statutory requirements to the implementation]. Aullen JP, Lassale B, Verdot JJ. Transfus Clin Biol; 2008 Nov; 15(5):217-22. PubMed ID: 18938098 [Abstract] [Full Text] [Related]
7. [Why is it necessary to review the December 15th 2003 circular relative to the transfusion act?]. Lassale B, Besse-Moreau M, Aullen JP. Transfus Clin Biol; 2014 Nov; 21(4-5):223-6. PubMed ID: 25267206 [Abstract] [Full Text] [Related]
8. The French Haemovigilance System: organization and results for 2003. Rebibo D, Hauser L, Slimani A, Hervé P, Andreu G. Transfus Apher Sci; 2004 Oct; 31(2):145-53. PubMed ID: 15501418 [Abstract] [Full Text] [Related]
9. Revised guidelines for compatibility testing in hospital blood banks: important changes for quality assurance and procedures. Voak D, Waters AH. Clin Lab Haematol; 1990 Oct; 12(2):235-6. PubMed ID: 2119933 [No Abstract] [Full Text] [Related]
10. Is the gift still good? Examining the politics and regulation of blood safety in the European Union. Farrell AM. Med Law Rev; 2006 Oct; 14(2):155-79. PubMed ID: 16831820 [No Abstract] [Full Text] [Related]
11. The Dublin Consensus Statement on vital issues relating to the collection of blood and plasma and the manufacture of plasma products. PLUS. Mahony BO, Turner A. Vox Sang; 2010 Apr; 98(3 Pt 2):447-50. PubMed ID: 20158697 [No Abstract] [Full Text] [Related]
12. Preparing for inspection: managing regulations and practices surrounding donors with positive infectious disease testing. Ferschke J. J Clin Apher; 2008 Apr; 23(6):191-5. PubMed ID: 18973114 [Abstract] [Full Text] [Related]
13. The European Blood Directive--its role in blood safety. Seitz R. Dev Biol (Basel); 2007 Apr; 127():147-52. PubMed ID: 17486887 [Abstract] [Full Text] [Related]
18. [What are the rules and regulations for blood product transfusion in France?]. Pélissier E, Bierling P. Rev Prat; 2009 Jan 20; 59(1):90-2. PubMed ID: 19253890 [Abstract] [Full Text] [Related]
19. Revisions to the requirements applicable to blood, blood components, and source plasma. Final rule. Food and Drug Administration, HHS. Fed Regist; 2001 Aug 06; 66(151):40886-90. PubMed ID: 11732557 [Abstract] [Full Text] [Related]
20. Transposition of the Blood Directive into national law--the perspective of Portugal. Gonçalves MH, Muon MC, Gonçalves Jd. Transfus Clin Biol; 2005 Feb 06; 12(1):18-20. PubMed ID: 15814287 [Abstract] [Full Text] [Related] Page: [Next] [New Search]